News

YourChoice Therapeutics Completes Phase 1a Clinical Study for Its Hormone-Free Male Birth Control Pill

YourChoice Therapeutics has achieved a significant milestone by completing its first-in-human clinical study for YCT-529, the pioneering hormone-free male birth control pill. Announced at the 2024 BIO International Convention, this development marks a breakthrough in contraceptive options, particularly for men. “We’re one step closer to delivering the world’s first male birth control pill,” said YourChoice Therapeutics Chief Science Officer Nadja Mannowetz. The…

The Significance of Early HPV Diagnosis and Novel Screening Solutions

May 2024 has been an exciting month for women’s health, with several significant advancements specifically in HPV testing and cervical cancer prevention. These innovations are are set to advance cervical health, as they help make screening more accessible, less invasive, and ultimately more effective in saving lives. These developments align with the World Health Organization’s (WHO) ambitious goal to eliminate cervical cancer as…

Women’s Health Research Round-up (June 3, 2024)

In recent years, there has been an increase in research focusing on women’s health, addressing various conditions, and exploring innovative solutions to improve health outcomes. This round-up article presents an overview of the latest studies published last week and their contributions to understanding and advancing women’s health. From understanding structural changes needed at the NIH to exploring the impact of social isolation…

Femtech Investment Round-up (May 2024)

Investment Reproductive health services company Rhea adds $10M in funding. Male reproductive health startup Posterity Health raises $6M to fund expansion and technology acceleration. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member…

GC Aesthetics Introduces FixNip NRI, a New Solution for Breast Reconstruction

GC Aesthetics, a company specializing in the design, manufacture, and distribution of breast implants and medical devices, has launched a new product aimed at improving breast reconstruction for women. The FixNip Nipple and Areola Reconstruction Implant (NRI) addresses a significant clinical need by providing a long-term aesthetic solution. FixNip NRI features a biocompatible smooth silicone structure with a floral-shaped nitinol frame. This…

Melinda French Gates Pledges $1 Billion to Empower Women Worldwide

In a bold move to further women’s rights and equality, Melinda French Gates has announced an additional $1 billion commitment through 2026 to advance women’s power worldwide. This initiative marks the first step in the next chapter of her philanthropic efforts. With significant setbacks in women’s rights and social progress both in the United States and globally, Gates emphasizes the urgency of…

Rhea Launches Global Reproductive Health Services Company and Acquires Embryonics; Adds Funding from Thiel Capital

Rhea, a global reproductive health services company, has officially launched, aiming to improve fertility journeys for modern families. The launch coincides with a follow-on funding round led by Thiel Capital, aimed at expanding Rhea’s global footprint and service offerings. Rhea is creating an end-to-end reproductive health ecosystem, connecting prospective families across Asia, North America, and Europe. The company’s services are centered around…

What’s New in Femtech This Week? (May 30, 2024)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Natural Cycles secures $55M Series C funding to accelerator growth ahead of possible IPO. Gameto secures $33M in Series B funding to advance novel IVF treatments. Male reproductive…